Sep 8, 2026 06:09AM
Jun 11, 2026 03:18AM
Mar 27, 2026 04:03AM
Mar 20, 2026 08:21AM
Mar 16, 2026 12:54PM
Feb 27, 2026 09:00AM
Feb 27, 2026 09:00AM Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
Nov 10, 2025 08:36AM
Oct 29, 2025 11:42AM
Oct 28, 2025 09:58AM
Oct 27, 2025 04:00PM
Oct 27, 2025 06:57AM
Oct 27, 2025 06:33AM
Oct 27, 2025 06:20AM H.C. Wainwright Downgrades Avidity Biosciences (RNA) to Neutral Post Novartis Acquisition
Oct 27, 2025 12:28AM
Aug 11, 2025 01:20AM
Aug 6, 2025 11:34AM
Jun 11, 2025 08:30AM
Apr 30, 2025 07:01AM
Feb 11, 2025 01:41AM
Nov 25, 2024 08:27AM BMO Capital Reiterates Outperform Rating on Novartis (NVS)
Nov 5, 2024 07:05AM
Nov 5, 2024 07:00AM
May 2, 2024 07:08AM
Feb 6, 2024 03:37AM
Feb 5, 2024 05:17PM
Feb 5, 2024 04:49PM
Feb 5, 2024 11:47AM Midday movers: Estee Lauder, Eli Lilly and more
Feb 5, 2024 11:33AM
Feb 5, 2024 11:28AM
Feb 5, 2024 10:18AM
Jan 11, 2024 04:50PM
Dec 14, 2023 06:05AM
Dec 7, 2023 08:49AM
Oct 26, 2023 07:53AM This biotech stock is seen as the next takeover with over 100% upside
Jun 30, 2023 08:20AM
Jun 30, 2023 07:12AM
Jun 12, 2023 04:19PM
Jun 12, 2023 03:46PM
Jun 12, 2023 05:22AM
Jun 12, 2023 01:23AM
Jun 8, 2023 07:00AM KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA
Mar 27, 2023 01:58PM
Dec 14, 2022 06:33AM
Jul 15, 2022 09:00PM
Jul 10, 2022 09:00PM
Nov 30, 2021 08:07AM
Oct 26, 2021 01:26AM
May 10, 2021 07:00AM Attralus Therapeutics Appoints Mark Timney as CEO and Expands Leadership Team with New Executives
Jan 6, 2020 12:05PM

1,186,894 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All